• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

作者信息

Rahier J F, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange E F, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis S P L, Colombel J F

出版信息

J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26.

DOI:10.1016/j.crohns.2009.02.010
PMID:21172250
Abstract
摘要

相似文献

1
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.欧洲关于炎症性肠病机会性感染预防、诊断和管理的循证共识
J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26.
2
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.欧洲关于炎症性肠病机会性感染预防、诊断和管理的第二项循证共识
J Crohns Colitis. 2014 Jun;8(6):443-68. doi: 10.1016/j.crohns.2013.12.013. Epub 2014 Mar 6.
3
Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium.炎症性肠病患者机会性感染的预防及欧洲克罗恩病和结肠炎组织（ECCO）共识在比利时的影响
Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):41-5.
4
Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication).炎症性肠病机会性感染的循证共识（再版）
Intest Res. 2018 Apr;16(2):178-193. doi: 10.5217/ir.2018.16.2.178. Epub 2018 Apr 30.
5
Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.炎症性肠病患者的机会性感染：预防与诊断
Gut. 2008 Apr;57(4):549-58. doi: 10.1136/gut.2006.114660. Epub 2008 Jan 4.
6
The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.生物制剂治疗炎症性肠病的机会性感染风险：最新进展。
Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1101-1108. doi: 10.1080/17474124.2018.1530983. Epub 2018 Oct 10.
7
[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease].[葡萄牙关于炎症性肠病贫血诊断、预防和治疗的共识]
Acta Med Port. 2016 Feb;29(2):144-56. doi: 10.20344/amp.6058. Epub 2016 Feb 29.
8
European consensus on the histopathology of inflammatory bowel disease.欧洲炎症性肠病组织病理学共识。
J Crohns Colitis. 2013 Nov;7(10):827-51. doi: 10.1016/j.crohns.2013.06.001. Epub 2013 Jul 17.
9
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.欧洲克罗恩病和结肠炎组织（ECCO）关于炎症性肠病感染的预防、诊断和管理指南
J Crohns Colitis. 2021 Jun 22;15(6):879-913. doi: 10.1093/ecco-jcc/jjab052.
10
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.炎症性肠病治疗相关的严重和机会性感染风险。
Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.

引用本文的文献

1
Biomarker discovery for non-invasive diagnosis of inflammatory bowel disease using blood transcriptomics.利用血液转录组学进行炎症性肠病非侵入性诊断的生物标志物发现
Front Immunol. 2025 Jun 20;16:1570374. doi: 10.3389/fimmu.2025.1570374. eCollection 2025.
2
Rare Finding of Rectal Squamous Metaplasia in Inflammatory Bowel Disease.炎症性肠病中罕见的直肠鳞状化生发现
ACG Case Rep J. 2025 Jan 17;12(1):e01598. doi: 10.14309/crj.0000000000001598. eCollection 2025 Jan.
3
An Unusual Case of an Immunocompetent Adult Diagnosed With Cytomegalovirus Colitis.
一例免疫功能正常的成年巨细胞病毒性结肠炎罕见病例。
Cureus. 2024 Apr 19;16(4):e58595. doi: 10.7759/cureus.58595. eCollection 2024 Apr.
4
Impact of an Intervention to Promote the Vaccination of Patients with Inflammatory Bowel Disease.一项促进炎症性肠病患者接种疫苗干预措施的影响
Vaccines (Basel). 2023 Oct 27;11(11):1649. doi: 10.3390/vaccines11111649.
5
Global research trends of immunotherapy and biotherapy for inflammatory bowel disease: a bibliometric analysis from 2002 to 2021.免疫治疗和生物疗法治疗炎症性肠病的全球研究趋势：2002 年至 2021 年的文献计量分析。
Biomed Eng Online. 2022 Jun 27;21(1):42. doi: 10.1186/s12938-022-01011-9.
6
Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review.硫唑嘌呤在溃疡性结肠炎中的应用：一项全面综述。
Cureus. 2022 May 10;14(5):e24874. doi: 10.7759/cureus.24874. eCollection 2022 May.
7
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature.英夫利昔单抗治疗克罗恩病导致心力衰竭：一例病例报告及文献综述
World J Clin Cases. 2021 Nov 26;9(33):10382-10391. doi: 10.12998/wjcc.v9.i33.10382.
8
Retrospective analysis of Clostridioides difficile and other intestinal infections in patients with Crohn's disease and ulcerative colitis in the tertiary hospital in Poland. POLIBD survey results.波兰三级医院克罗恩病和溃疡性结肠炎患者艰难梭菌及其他肠道感染的回顾性分析。POLIBD调查结果。
Gut Pathog. 2021 Dec 13;13(1):73. doi: 10.1186/s13099-021-00471-z.
9
Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases.韩国炎症性肠病患者疫苗接种不足和免疫接种率低。
Medicine (Baltimore). 2021 Nov 12;100(45):e27714. doi: 10.1097/MD.0000000000027714.
10
Environmental Pollutants, Mucosal Barriers, and Pathogen Susceptibility; The Case for Aflatoxin B as a Risk Factor for HIV Transmission and Pathogenesis.环境污染物、黏膜屏障与病原体易感性；黄曲霉毒素B作为HIV传播和发病风险因素的案例
Pathogens. 2021 Sep 23;10(10):1229. doi: 10.3390/pathogens10101229.